TR-GLP2
40mgDual GIP/GLP-1 receptor agonist research peptide. Lyophilised vial for reconstitution.
RM 320.00
Out of stock
- Independently testedCertificate per batch
- Lyophilised & sealedSterile single vial
- Ships from MalaysiaPlain packaging, next workday dispatch
RT-GLP3
30mg
Triple-receptor research peptide (GLP-1/GIP/glucagon). Lyophilised vial for reconstitution.
RM 290.00
1
Included free with every order
- Bacteriostatic waterThe solvent this vial needs — nothing else to buy
- Premium reconstitution tool set3 mL reconstitution syringe, 50IU syringes, alcohol swabs
RT-GLP3 is our coded name for Retatrutide, a triple-receptor research peptide that activates GLP-1, GIP, and glucagon receptor pathways in a single molecule. It is one of the most closely studied compounds in current metabolic-research literature, with published Phase 2 trial data describing dose-dependent effects on body weight and glycaemic markers in adults with obesity. This vial ships lyophilised for reconstitution, strictly for laboratory and research use.
Studied for
- Triple agonism at GLP-1, GIP and glucagon receptors in metabolic-research models
- Dose-ranging body-weight research in randomised controlled trials
- Glycaemic-marker and appetite-regulation research
A typical dose referenced in published research literature is 1–12 mg, administered subcutaneously once weekly — the dose range used in the published Phase 2 trial.
What is in the vial
| Component | Mass | Research profile | Profile |
|---|---|---|---|
| Retatrutide | 30 mg | Triple GLP-1/GIP/glucagon receptor agonist research | Wiki → |
Third-party testing
A manufacturer's own purity figure is not independent verification. Every batch we sell is tested by an independent laboratory before it is offered.
Certificate of Analysis is on file for every batch and available on request.
What the literature actually says
Independent published research on this material. We link to the source rather than summarising it.
What this blend has not been shown to do
Retatrutide has not been evaluated for safety beyond the published trial periods, and the Phase 2 data above documents significant loss of lean body mass alongside fat loss — a trade-off the source literature discusses directly, not one we are adding as a caveat.
Storage
| Unreconstituted powder | |
|---|---|
| −20 °C | 24 months |
| 2–8 °C | 6 months |
| Room temperature | 30 days |
| Reconstituted solution | |
| 2–8 °C | 30 days |
| +15 °C | Caution — only 7 days |
| +30 °C | Caution — only 24 hours |
| Below 0 °C | Do not use. Discard |
Never freeze a reconstituted vial — a frozen solution is spoiled.
Reconstitution
- Let the vial reach room temperature before opening — cold glass pulls condensation.
- Swab the stopper. Use bacteriostatic water, or acetic acid where the compound calls for it.
- Run the solvent slowly down the inside wall, never onto the powder.
- Swirl gently. Do not shake — agitation shears the peptide.
- Let it stand 5–10 minutes until fully in solution before drawing.
- Refrigerate at 2–8 °C immediately once reconstituted.
- Never freeze it. Below 0 °C the solution is spoiled — discard the vial.
Work out your draw
Our calculator opens pre-filled for a 30mg vial — enter your target dose and it returns the draw in units.
Open the calculatorFrequently paired with